Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Gavi

- PMLiVE

Coronavirus disruption scuppers Curium Pharma sale

London-based private equity firm CapVest will wait for market to improve

- PMLiVE

COVID-19: Novel coronavirus remains stable on surfaces for hours

Researchers find virus stays on surfaces for several hours to days

- PMLiVE

UK biotech Synairgen to begin COVID-19 trial of lead candidate

Company enters the race to find a therapeutic as virus cases rise

- PMLiVE

Novartis launches $20m COVID-19 response fund

Financial grants will be issued to most impacted communities

- PMLiVE

Biogen joins COVID-19 efforts with $10m support fund

Funds will be used to address 'immediate critical needs'

- PMLiVE

First patients dosed with Moderna’s COVID-19 vaccine

More pharma players also join vaccine development efforts

- PMLiVE

UK ramps up measures to combat coronavirus spread

New advice encourages ‘social-distancing’ as cases expected to soar

- PMLiVE

Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19

The interleukin-6 inhibitor will be evaluated in critically ill patients

- PMLiVE

CEPI says $2bn is needed for COVID-19 vaccine development

Funding will be used to take candidates through all stages of development

- PMLiVE

Did Trump offer CureVac $1bn for COVID-19 vaccine rights?

Media reports claim Trump administration tried to secure exclusive rights

- PMLiVE

Lilly and AbCellera partner on antibody therapies for COVID-19

Latest companies to join the fight against the novel coronavirus

Roche Basel Switzerland

FDA okays Roche’s COVID-19 diagnostic test

Increases capacity for testing as coronavirus cases grow

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links